DeepMed Research

BAXTER HEALTHCARE CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

Phase 1

Completed

Conditions: Healthy

First Posted Date: 2006-08-01

Last Posted Date: 2007-03-13

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT00358553

Locations: 🇩🇪
Profil, Neuss, Germany

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

Not Applicable

Completed

Conditions: Liver Failure
Hepatitis, Chronic
Liver Cirrhosis
Hepatic Encephalopathy

Interventions: Device: MARS
Drug: Standard Medical Therapy

First Posted Date: 2006-02-06

Last Posted Date: 2025-03-03

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 70

Registration Number: NCT00287235

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇩🇰
University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark
🇺🇸
University of Alabama, Birmingham, Alabama, United States

and more 5 locations

A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis

Phase 3

Completed

Conditions: End Stage Renal Disease

First Posted Date: 2005-09-22

Last Posted Date: 2025-03-03

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 120

Registration Number: NCT00214721

Locations: 🇨🇦
St. Paul's Hospital, Vancouver, British Columbia, Canada

A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis

Not Applicable

Completed

Conditions: End Stage Renal Disease

First Posted Date: 2005-09-22

Last Posted Date: 2025-02-27

Lead Sponsor: Vantive Health LLC

Target Recruit Count: 20

Registration Number: NCT00214695

Locations: 🇸🇪
Huddinge Sjukhus, Njurmed kliniken K 56, Huddinge, Sweden

Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

Completed

Conditions: Femoral Vascular Anastomosis

First Posted Date: 2005-09-14

Last Posted Date: 2006-10-23

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 60

Registration Number: NCT00163592

Locations: 🇦🇹
General Hospital (AKH) Salzburg, Salzburg, Austria
🇩🇪
Leonberg Hospital, Department of Vascular Surgery, Leonberg, Germany
🇦🇹
Landeskrankenhaus Innsbruck, Innsbruck, Tirol, Austria

and more 2 locations

Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures

Phase 2

Completed

Conditions: Sinus Implant Reconstruction

First Posted Date: 2005-09-14

Last Posted Date: 2007-11-15

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 86

Registration Number: NCT00163605

Locations: 🇩🇪
Klinik für Mund-, Kiefer- und Gesichtschirurgie des Helios-Klinikums Erfurt, Erfurt, Germany
🇩🇪
Universitätsklinikum Schleswig Holstein, Campus Kiel, Kiel, Germany
🇩🇪
Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie der Universität Erlangen-Nürnberg, Erlangen, Germany

Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

Phase 3

Completed

Conditions: Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy
Cardiopulmonary Bypass
Sternotomy

First Posted Date: 2005-09-13

Last Posted Date: 2017-04-05

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT00161733

Locations: 🇺🇸
Brevard Cardio Surgeons/Health First Heart Institute, Melbourne, Florida, United States
🇺🇸
Peachtree Cardiovascular, Atlanta, Georgia, United States
🇺🇸
St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States

and more 19 locations

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Phase 3

Completed

Conditions: Breast Cancer
Lumpectomy
Mastectomy Plus Axillary Lymph Node Dissection
Lymphatic Leakage

First Posted Date: 2005-09-13

Last Posted Date: 2006-10-23

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT00161980

Locations: 🇫🇷
Centre Régional de Lutte Contre le Cancer, Centre Eugène Marquis, Rennes, France
🇮🇹
S. Luigi - S. Curro, Presidi Ospedalieri Unificati, Catania, Italy
🇩🇪
Ludwig-Maximilians-Universität, Munich, Germany

and more 5 locations

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Phase 3

Completed

Conditions: Hip Replacement Surgery

First Posted Date: 2005-09-13

Last Posted Date: 2006-10-23

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT00161902

Locations: 🇳🇱
Academisch Ziekenhuis Maastricht, Orthopedic Surgery, Maastricht, Netherlands
🇳🇱
St. Anna Ziekenhuis, Orthopedic Surgery, Geldrop, Netherlands
🇳🇱
St. Clara Ziekenhuis, Orthopedic Surgery, Rotterdam, Netherlands

and more 4 locations

Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices

Phase 3

Completed

Conditions: Esophageal and/or Gastric Varices

First Posted Date: 2005-09-13

Last Posted Date: 2006-10-23

Lead Sponsor: Baxter Healthcare Corporation

Registration Number: NCT00161915

Locations: 🇩🇪
Krankenhaus Zehlendorf, Berlin, Germany
🇩🇪
St. Elisabeth Krankenhaus, Wittlich, Germany
🇩🇪
Krankenhaus Lichtenberg, Berlin, Germany

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy